A ‘Gutsy’ Approach to Predict Immunotherapy Responses
Researchers developed a model that uses the gut microbiome to predict if a patient's tumor would have a response...
Author:
Neha J. Pancholi, PhD
Researchers developed a model that uses the gut microbiome to predict if a patient's tumor would have a response...
This quarter's round-up of cutting-edge cancer research includes a way to fight chemo brain, controlling cancer cell death, and...
Learn how liquid biopsy could be used to detect cancer and guide treatment as researchers work to develop more...
Learn about cancer vaccines, including the various types used to treat or prevent cancer, and discover what's on the...
Learn about the types of cancer immunotherapy including immune checkpoint inhibitors, ACT, therapeutic vaccines, and more.
During his Presidential Address at the AACR Annual Meeting 2024, Philip D. Greenberg discussed research driving immunotherapy forward.
Learn about synthetic lethality and approved drugs that use this approach to treat cancer.
The journey to the first approved TIL therapy began with Steven A. Rosenberg over 30 years ago.
Researchers discussed AI's impact on the diagnosis and treatment of cancer at the AACR Annual Meeting 2024.
The latest installment of this quarterly series highlights innovative research approaches reported at the AACR Annual Meeting 2024.